Oak Street Health (NYSE:OSH) Now Covered by Stifel Nicolaus

Equities researchers at Stifel Nicolaus assumed coverage on shares of Oak Street Health (NYSE:OSHGet Rating) in a note issued to investors on Thursday, The Fly reports. The brokerage set a “buy” rating on the stock.

Several other research analysts have also commented on the stock. Cowen upgraded shares of Oak Street Health from a “market perform” rating to an “outperform” rating and raised their price target for the company from $25.00 to $30.00 in a report on Thursday, March 17th. Barclays lifted their price objective on shares of Oak Street Health from $27.00 to $31.00 and gave the company an “overweight” rating in a research note on Tuesday, April 19th. Canaccord Genuity Group dropped their price objective on shares of Oak Street Health from $49.00 to $29.00 in a research note on Wednesday, March 2nd. The Goldman Sachs Group dropped their price objective on shares of Oak Street Health from $68.00 to $37.00 and set a “buy” rating on the stock in a research note on Monday, March 21st. Finally, Zacks Investment Research upgraded shares of Oak Street Health from a “sell” rating to a “hold” rating in a research note on Thursday, May 19th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Oak Street Health currently has an average rating of “Buy” and an average price target of $36.77.

Shares of OSH traded up $0.89 during mid-day trading on Thursday, hitting $18.26. The company had a trading volume of 55,550 shares, compared to its average volume of 2,951,288. The business’s 50-day simple moving average is $21.84 and its 200-day simple moving average is $24.62. The company has a quick ratio of 1.79, a current ratio of 1.79 and a debt-to-equity ratio of 16.10. Oak Street Health has a 1-year low of $13.29 and a 1-year high of $65.22. The stock has a market cap of $4.40 billion, a PE ratio of -9.22 and a beta of 2.41.

Oak Street Health (NYSE:OSHGet Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.04). Oak Street Health had a negative net margin of 26.82% and a negative return on equity of 413.94%. The business had revenue of $513.80 million during the quarter, compared to analysts’ expectations of $506.82 million. During the same quarter in the previous year, the business posted ($0.29) EPS. The company’s quarterly revenue was up 73.2% on a year-over-year basis. On average, sell-side analysts expect that Oak Street Health will post -2.2 earnings per share for the current year.

In other news, insider Geoffrey M. Price sold 60,000 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $26.56, for a total transaction of $1,593,600.00. Following the completion of the transaction, the insider now owns 3,871,377 shares of the company’s stock, valued at $102,823,773.12. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Geoffrey M. Price sold 80,000 shares of the business’s stock in a transaction on Tuesday, March 22nd. The shares were sold at an average price of $24.83, for a total transaction of $1,986,400.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 275,000 shares of company stock valued at $6,529,450. 11.40% of the stock is currently owned by corporate insiders.

Institutional investors and hedge funds have recently made changes to their positions in the company. CI Investments Inc. bought a new stake in shares of Oak Street Health during the third quarter valued at about $28,000. Benjamin Edwards Inc. raised its stake in shares of Oak Street Health by 9,016.7% during the first quarter. Benjamin Edwards Inc. now owns 1,094 shares of the company’s stock valued at $29,000 after purchasing an additional 1,082 shares in the last quarter. Confluence Wealth Services Inc. bought a new stake in shares of Oak Street Health during the fourth quarter valued at about $34,000. Fifth Third Bancorp bought a new stake in Oak Street Health in the first quarter worth about $46,000. Finally, Canada Pension Plan Investment Board bought a new stake in Oak Street Health in the fourth quarter worth about $46,000. 91.42% of the stock is owned by institutional investors.

Oak Street Health Company Profile (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

The Fly logo

Analyst Recommendations for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.